Boiron SA (BOI) Stock Price & News

BOI:EPA

Boiron SA

€ १८.४०

+१.३८%

(+०.२५) 1D

अक्टोबर २०, ०९:३८:४९ GMT+२ · EUR

All symbols

	Symbol	Price	Change	% Change

Generating top insights for BOI...

Open

€ १८.१५

High

€ १८.४०

Low

€ १८.१०

Mkt. cap

३२.२८ करोड

Avg. vol.

५.५० हजार

Volume

६७०.००

P/E ratio

१२.२०

52-wk high

€ ३२.००

52-wk low

€ १६.९०

EPS

€ १.५१

Shares outstanding

१.७५ करोड

No. of employees

३ हजार

Open

€ १८.१५

High

€ १८.४०

Low

€ १८.१०

Mkt. cap

३२.२८ करोड

Avg. vol.

५.५० हजार

Volume

६७०.००

P/E ratio

१२.२०

52-wk high

€ ३२.००

52-wk low

€ १६.९०

EPS

€ १.५१

Shares outstanding

१.७५ करोड

No. of employees

३ हजार

Related stocks

Compagnie des Alpes SA

News stories

From web sources and news partners

Simply Wall Street

१६ मिनेट पहिले

Why Is TTM Technologies (TTMI) Buying Ophir Optics For $650 Million?

TradingView

१ घण्टा पहिले

Asia’s Bitcoin Play Hits Wall Street: Metaplanet Set to Buy This Nasdaq-Listed Company for BTC Treasury Operations

Yahoo Finance

३३ मिनेट पहिले

US Stock Market Today: S&P 500 Futures Climb On Strong Factory And Earnings Hopes

CNBC

७ घण्टा पहिले

CNBC Daily Open: Tech investors buy the dip — but debt remains a concern

Profile

Boiron is a manufacturer of homeopathic products, headquartered in France and with an operating presence in 59 countries worldwide. It is the largest manufacturer of homeopathic products in the world. In 2004, it had a workforce of 2,779 and turnover of € 313 million. It is a member of the CAC Small stock index. In June 2005, the firm acquired Dolisos Laboratories, then the world's second largest manufacturer of homeopathic preparations. Products of Boiron include mono- and poly-preparations, which Boiron refer to as "proprietary drugs". Homeopathy is a pseudoscience with no evidence of effectiveness for stated claims or plausible mechanism of medicinal effect, and several class action lawsuits have been filed on behalf of consumers claiming that Boiron's homeopathic products, including Children's Coldcalm and Oscillococcinum, are useless and Boiron's marketing of these products is deceptive. Wikipedia

About Boiron SA

CEO-

Employees२.६२ हजार

Founded१९३२ जुन ७

Headquarters-

Sector-

Websiteboiron.fr

Revenue

Net income

All values in EUR	२०२५ सेप्टेम्बर	२०२५ डिसेम्बर	२०२६ मार्च	२०२६ जुन
Revenue	१२.७७ करोड	१२.७७ करोड	१२.०२ करोड	१२.०२ करोड
Cost of goods sold	३.५४ करोड	३.५४ करोड	३.३५ करोड	३.३५ करोड
Cost of revenue	३.५४ करोड	३.५४ करोड	३.३५ करोड	३.३५ करोड
Research and development expenses	१५.६० लाख	१५.६० लाख	१४.४० लाख	१४.४० लाख
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	७.९३ करोड	७.९३ करोड	८.०० करोड	८.०० करोड
Operating expense	७.७५ करोड	७.७५ करोड	८.१९ करोड	८.१९ करोड
Total operating expenses	११.२९ करोड	११.२९ करोड	११.५४ करोड	११.५४ करोड
Operating income	१.४८ करोड	१.४८ करोड	४७.५५ लाख	४७.५५ लाख
Other non operating income	-११.२८ लाख	-११.२८ लाख	-२२.९१ लाख	-२२.९१ लाख
EBT including unusual items	१.३८ करोड	१.३८ करोड	४०.२० लाख	४०.२० लाख
EBT excluding unusual items	१.३२ करोड	१.३२ करोड	२७.५२ लाख	२७.५२ लाख
Income tax expense	३१.७६ लाख	३१.७६ लाख	१५.६४ लाख	१५.६४ लाख
Effective tax rate	२२.९९%	२२.९९%	३८.९०%	३८.९०%
Other operating expenses	-३३.०४ लाख	-३३.०४ लाख	४.८८ लाख	४.८८ लाख
Net income	१.०६ करोड	१.०६ करोड	२४.५५ लाख	२४.५५ लाख
Net profit margin	८.३३%	८.३३%	२.०४%	२.०४%
Earnings per share	-	-	-	-
Interest and investment income	६.५३ लाख	६.५३ लाख	६.३६ लाख	६.३६ लाख
Interest expense	-३.३५ लाख	-३.३५ लाख	-४.१० लाख	-४.१० लाख
Net interest expenses	३.१८ लाख	३.१८ लाख	२.२६ लाख	२.२६ लाख
Depreciation and amortization charges	-	-	-	-
EBITDA	१.८१ करोड	१.८१ करोड	१.१२ करोड	१.१२ करोड
Gain or loss from assets sale	-४.४६ लाख	-४.४६ लाख	-	-

Ask anything